The CD34 antigen is present on 1-4% of human marrow 
Introduction
Studies of human hematopoietic stem cells have been limited by the inability to identify and isolate these progenitor cells from marrow. Monoclonal antibody technology has made it possible to characterize cell surface antigens expressed by human hematopoietic progenitors and their progeny (1, 2) . The CD34 antigen identified by antibodies 12-8, MY-10, BI-3C5, and ICH3 is of particular interest because it is primarily found on immature hematopoietic elements in human marrow (3) (4) (5) (6) . Nearly all colony-forming progenitors, granulocyte-macrophage colony-forming units (CFU-GM)', erythroid burst-forming units (BFU-E), and multipotential colony-forming units (CFU-MIX), detectable with in vitro assays express the CD34 antigen. Antibody 12-8 also identifies the precursors of colony-forming cells in long-term marrow culture (5) . In nonhuman primates, this antibody also reacts with 1 . Abbreviations used in this paper: BFU-E, erythroid burst-forming unit; CFU-GM, granulocyte-macrophage colony-forming unit; CFU-MIX, multipotential colony-forming unit.
1-4% of marrow cells that contain virtually all hematopoietic
colony-forming progenitors (7) . To test whether CD34' marrow cells were capable of restoring hematopoiesis in vivo, lethally irradiated baboons were transplanted with autologous CD34' marrow cells enriched by avidin-biotin immunoadsorption chromatography (8) (9) (10) (11) .
Methods

Baboons (Papio cynocephalus) and animal treatment
Baboons that were born at the University of Washington Regional Primate Center were placed in isolation and dewormed prior to use. The animals weighed 3.9-5.4 kg and ranged 1-2 yr in age. Research was conducted at the Primate Center under conditions that met National Institutes of Health standards as stated in the Guide for the Care and Use of Laboratory Animals (DHEW Publication No. NIH 1985) , Institute of Laboratory Animal Resources recommendations, and American Association for Accreditation of Laboratory Animal Care accreditation standards for animals of this species. A central venous catheter was placed in all animals. Marrow was obtained by aspiration of both femora and processed using previously established procedures (12) . After marrow aspiration, all animals were given 9.2 Gy of total body irradiation as a single exposure delivered from two opposing 6Co sources at a rate of 7 cGy/min.
Peripheral blood counts were determined daily until normal counts were achieved and then weekly thereafter. Serum electrolytes as well as other laboratory tests and X-rays were performed as clinically indicated. Parenteral fluid and electrolytes were given based on clinical status (e.g., vomiting and diarrhea) and laboratory values. Prophylactic antibiotics (piperacillin 100 mg/kg t.i.d. and gentamicin 1.7 mg/kg t.i.d.) were administered intravenously starting immediately posttransplant and continued until animals achieved a granulocyte count > 500/mm3. The animals were given whole blood transfusions from random baboons for treatment of severe and life-threatening anemia and thrombocytopenia. All blood products used for transfusion were irradiated in vitro (15 Gy) . Gross and histologic postmortem examinations were carried out on all animals that died.
Antibodies and immunofluorescence staining reagents Antibody 12-8 (murine IgM isotype) was partially purified from ascites fluid using boric acid precipitation (13) . Affinity-purified goat antimouse IgM antiserum was obtained from Southern Biotechnology Associates, Inc. (Birmingham, AL) and biotinylated as previously described (9) . The fluorescein isothiocyanate conjugate of avidin (avidin-FITC) was obtained from Vector Laboratories (Burlingame, CA).
Coupling of avidin to the gel was nearly quantitative under these conditions so that each milliliter of gel used for positive selection contained 100 ,g ofavidin and each ml ofgel used for depletion contained Isolation of CD34' cells. The antibody-treated cells were passed over a Chromaflex 15 X 2.5-cm column (Kontes Co., Vineland, NJ) containing 20 ml avidin-Biogel (100 Mg/ml avidin) at a flow rate of 6-12 ml/min until a total volume of -100 ml had been collected.
-50 ml of PBS was then passed through the gel at the same flow rate to wash out BSA. The adherent cells were dislodged by mechanical agitation with a 10-ml pipette until a total volume of 100 ml had been collected. The recovered adherent cells were directly infused in three animals.
In two animals, recovered adherent cells were further separated by FACS prior to infusion. In this procedure, the adherent cells at a concentration of I07 cells/ml were incubated with a 1:100 dilution of avidin-FITC in PBS/BSA for 30 min at 4VC. The cells were washed twice and then separated by flow microfluorimetric sorting on a FACS IV (Becton Dickinson Immunocytometry Systems, Mountain View, CA) as previously described (5) . The cells with a level of fluorescence intensity > 98% ofunlabeled cells were collected and infused into these two animals.
Depletion of CD34' cells. Nucleated marrow cells were treated successively with antibody 12-8 and biotinylated goat anti-mouse IgM antiserum as described above. These cells at a concentration of 75 X 106 cells/ml were passed over a Chromaflex 25 X 2.5-cm column containing 100 ml of avidin-Biogel (1 mg/ml avidin) at a flow rate of I ml/min. The nonadherent cells that washed through the column were collected and infused.
Immunofluorescence studies
The percentage of cells reactive with antibody 12-8 was determined by immunofluorescence staining and flow microfluorimetric analysis by using an indirect immunofluorescence procedure (9, 10 (14) . Cultures were incubated at 370C, 5% CO2 in a humidified incubator and scored for different colony types after 14-16 d using an inverted microscope.
Results
Transplantation ofenriched CD34' cells. Using antibody 12-8, cells expressing the CD34 antigen were positively selected from the marrows (0.8-3.6 X l10 cells) of five baboons (Table   I ). In three experiments, 20-27 X 106 cells adherent to the column were recovered. These cells were 65-81% CD34' and represented 1.6-2.5% of the starting cell number applied to the column. Fig. 1 shows an example of the enrichment of CD34' cells in the column adherent population compared with the unseparated marrow cells from one of the baboons. In two additional experiments, recovered column-adherent cells were separated by flow microfluorimetric sorting to further enrich CD34' cells. This yielded 19 and 15 X 106 cells that were 85 and 91% CD34' and accounted for 0.5% and 0.6% of the starting number of marrow cells, respectively. The committed hematopoietic progenitors including CFU-GM, BFU-E, and CFU-MIX were enriched in the positively selected cell populations (Table II) . The CD34-cells isolated by flow microfluorimetric sorting from the column-adherent population contained few colony-forming cells.
After 9.2 Gy of total body irradiation, the five animals (Table I) . Marrow aspirates and biopsies obtained 3-4 wk after transplantation showed normal marrow cellularity and the presence of all hematopoietic lineages in all animals. Fig. 2 shows that the temporal pattern of recovery of leukocytes and platelets in these baboons was similar to that observed in control animals given unprocessed marrow (see below).
Transplantation of marrow depleted of CD34' cells. Two animals received 0.9 and 1.2 X 109 cells (184 and 285 X 106 cells/kg, respectively) depleted of CD34+ cells by immunoadsorption with antibody 12-8 (Table I ). This treatment resulted in a 1-2-log reduction in detectable colony-forming cells (Table II) . One animal died at day 29 without evidence of engraftment. The second animal demonstrated marrow aplasia for > 2 mo after transplantation. This animal had a granulocyte count < 100, platelet count < 20,000, and continued to require transfusions for > 100 d posttransplant. This baboon continued to have severe myeloid hypoplasia documented on serial marrow examinations until its death on day 227.
Control animals. Three animals received 206, 218, and 270 X 106 cells/kg of unprocessed marrow after total body irradiation. Two animals engrafted with a temporal pattern of hematologic recovery similar to that of the animals transplanted with CD34+ cells (Table I and Fig. 2) . The third animal developed severe gastrointestinal bleeding and died at day 19 posttransplant with a total white blood cell count of 1,500, a granulocyte count of 172 (day 15), a platelet count of 7,000/mm3, 
Discussion
Several monoclonal antibodies have been developed that identify the CD34 antigen expressed by early human hematopoietic progenitors detected by in vitro assays (3) (4) (5) (6) . One of these antibodies, 12-8, has the unique property of recognizing a distinct epitope that is also present on a similar marrow population in non-human primates (7) . In the present study, highly enriched populations of CD34+ cells isolated from baboon marrow were capable of completely restoring hematopoiesis when transplanted into lethally irradiated animals. The rate of engraftment in these animals was similar to that of control animals transplanted with unseparated marrow and was similar to that reported in previous studies of autografts in lethally irradiated nonhuman primates (15, 16) . Two animals received CD34+ cells that were further enriched by flow microfluorimetric sorting after immunoadsorption and demonstrated prompt engraftment and complete hematologic recovery. Therefore, the CD34-cells contaminating the adsorbed cell population are unlikely to have played a role in restoring hematopoiesis. The rapid and durable engraftment for more than 6 mo and 1 yr in these two animals suggests that the stem cells that produce hematopoietic reconstitution are contained 
